Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Biofil Chemicals And Pharmaceuticals Limited
Since 1985, Biofil Chemicals And Pharmaceuticals Limited has maintained a presence in the industry for 41 years. The company is identified by CIN L24233MP1985PLC002709 and reg. no. 2709. It belongs to the classification of company limited by shares as per MCA records. Biofil Chemicals And Pharmaceuticals Limited is authorized to hold share capital worth ₹20.00 crore. Its paid up capital is ₹16.27 crore.
The company’s main operations are related to manufacture of chemicals and chemical products. The company has been registered in the city of Gwalior. The company’s incorporation address is B/12-b, Industrial Estate, Pologround, Industrial Estate (indore), Indore, Indore, Madhya Pradesh, India, 452015. It is an active company at present. The company’s Permanent Account Number (PAN) is AAACB9569Q. The company’s Legal Entity Identifier (LEI) code is 89450040Q8MG7L3DZG70. You can reach the company via email at bcplcompliance@gmail.com. At the helm are Pavan Singh Rajput (CFO) and Pavan Singh Rajput (CFO).
Company Overview
- CIN
- Date of Incorporation
- 03/01/1985
- Company Status
- Active
- RoC
- Gwalior
- Registration Number
- Balance sheet date
- 31/03/2025
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹20,00,00,000.00
- Paid up Capital
- ₹16,27,38,000.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- bcplcompliance@gmail.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Madhya Pradesh | 23AAACB9569Q2ZZ | Active |
| 23AAACB9569Q1Z0 | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN8829A01013 | BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | BIOFIL CHEMPHAM/SH VTG | ESVUFN |
| INE829A01014 | BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED EQ | - | 12/10/2026 | BIOFIL CHEMPHAM/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹693.51L | ₹834.48L | ₹862.43L | ₹900.08L | ₹0.00L |
| Net Debt | ₹295.62L | ₹33.88L | ₹34.63L | ₹48.46L | ₹0.00L |
| Gross PPE | ₹876.91L | ₹0.00L | ₹1,165.05L | ₹1,162.76L | ₹1,161.71L |
| Inventory | ₹399.97L | ₹334.14L | ₹254.97L | ₹121.34L | ₹0.00L |
| Total Debt | ₹302.00L | ₹47.13L | ₹43.89L | ₹52.23L | ₹0.00L |
| Common Stock | ₹1,627.38L | ₹1,627.38L | ₹1,627.38L | ₹1,627.38L | ₹0.00L |
| Current Debt | ₹302.00L | ₹47.13L | ₹43.89L | ₹52.23L | ₹0.00L |
| Share Issued | ₹162.74L | ₹162.74L | ₹162.74L | ₹162.74L | ₹0.00L |
| Total Assets | ₹4,284.81L | ₹5,096.04L | ₹4,708.27L | ₹3,140.57L | ₹0.00L |
| Capital Stock | ₹1,627.38L | ₹1,627.38L | ₹1,627.38L | ₹1,627.38L | ₹0.00L |
| Current Assets | ₹3,586.27L | ₹4,255.36L | ₹3,840.76L | ₹2,235.41L | ₹0.00L |
| Prepaid Assets | ₹93.16L | ₹0.00L | ₹51.89L | ₹60.03L | ₹24.80L |
| Working Capital | ₹1,517.35L | ₹1,070.59L | ₹988.31L | ₹862.86L | ₹0.00L |
| Invested Capital | ₹2,458.43L | ₹1,925.29L | ₹1,864.17L | ₹1,782.38L | ₹0.00L |
| Other Properties | ₹20.98L | ₹0.00L | ₹24.33L | ₹24.33L | ₹24.33L |
| Retained Earnings | -₹2,833.29L | -₹3,111.58L | -₹3,169.44L | -₹3,259.57L | ₹0.00L |
| Common Stock Equity | ₹2,156.43L | ₹1,878.14L | ₹1,820.28L | ₹1,730.15L | ₹0.00L |
| Net Tangible Assets | ₹2,156.43L | ₹1,878.14L | ₹1,820.28L | ₹1,730.15L | ₹0.00L |
| Tangible Book Value | ₹2,156.43L | ₹1,878.16L | ₹1,820.28L | ₹1,730.15L | ₹0.00L |
| Current Liabilities | ₹2,068.92L | ₹3,184.77L | ₹2,852.45L | ₹1,372.55L | ₹0.00L |
| Stockholders Equity | ₹2,156.43L | ₹1,878.16L | ₹1,820.28L | ₹1,730.15L | ₹0.00L |
| Other Equity Interest | ₹529.05L | ₹250.78L | ₹192.90L | ₹102.77L | ₹0.00L |
| Total Capitalization | ₹2,156.43L | ₹1,878.16L | ₹1,820.28L | ₹1,730.15L | ₹0.00L |
| Ordinary Shares Number | ₹162.74L | ₹162.74L | ₹162.74L | ₹162.74L | ₹0.00L |
| Other Non Current Assets | -₹0.01L | ₹6.20L | -₹0.01L | -₹0.01L | ₹0.00L |
| Total Non Current Assets | ₹698.53L | ₹840.68L | ₹867.51L | ₹905.16L | ₹0.00L |
| Cash And Cash Equivalents | ₹332.65L | ₹25.53L | ₹228.35L | ₹3.77L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Accumulated Depreciation | -₹183.40L | -₹340.58L | -₹302.62L | -₹262.68L | ₹0.00L |
| Additional Paid In Capital | ₹833.31L | ₹0.00L | ₹833.31L | ₹833.31L | ₹833.31L |
| Other Short Term Investments | ₹326.26L | ₹12.28L | ₹219.09L | ₹1.17L | ₹0.00L |
| Other Non Current Liabilities | ₹0.01L | -₹0.01L | ₹0.00L | ₹0.00L | -₹0.01L |
| Machinery Furniture Equipment | ₹217.09L | ₹399.97L | ₹389.97L | ₹389.89L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹2,156.43L | ₹1,878.16L | ₹1,820.28L | ₹1,730.15L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹2,128.38L | ₹3,217.88L | ₹2,887.99L | ₹1,410.42L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹302.00L | ₹47.13L | ₹43.89L | ₹52.23L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹332.65L | ₹25.53L | ₹228.35L | ₹3.77L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹59.46L | ₹33.13L | ₹35.54L | ₹37.87L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | -₹80.54L | -₹202.38L | ₹237.08L | -₹12.24L | ₹0.00L |
| Changes In Cash | ₹307.11L | -₹202.83L | ₹224.59L | -₹10.73L | ₹0.00L |
| End Cash Position | ₹332.65L | ₹25.53L | ₹228.35L | ₹3.76L | ₹0.00L |
| Financing Cash Flow | ₹253.86L | -₹0.45L | -₹12.49L | ₹1.51L | ₹0.00L |
| Investing Cash Flow | ₹113.74L | -₹10.01L | -₹2.29L | -₹1.06L | ₹0.00L |
| Operating Cash Flow | -₹60.49L | -₹192.37L | ₹239.37L | -₹11.18L | ₹0.00L |
| Capital Expenditure | -₹20.05L | -₹10.01L | -₹2.29L | -₹1.06L | ₹0.00L |
| Beginning Cash Position | ₹25.53L | ₹228.35L | ₹3.76L | ₹14.49L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.01L | ₹0.00L | ₹0.00L | -₹0.01L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹345.87L | ₹77.22L | ₹90.68L | ₹83.49L | ₹0.00L |
| EBITDA | ₹373.07L | ₹115.18L | ₹130.62L | ₹126.40L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹278.60L | ₹55.77L | ₹70.92L | ₹56.04L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹243.44L | ₹255.61L | ₹252.78L | ₹261.19L | ₹0.00L |
| Pretax Income | ₹344.96L | ₹73.61L | ₹86.53L | ₹79.30L | ₹0.00L |
| Tax Provision | ₹66.36L | ₹17.83L | ₹15.61L | ₹23.26L | ₹0.00L |
| Total Revenue | ₹2,839.52L | ₹3,340.22L | ₹4,003.53L | ₹3,003.52L | ₹0.00L |
| Cost Of Revenue | ₹2,596.08L | ₹3,084.61L | ₹3,812.09L | ₹2,742.33L | ₹0.00L |
| Total Expenses | ₹2,801.79L | ₹3,293.42L | ₹3,961.81L | ₹2,929.66L | ₹0.00L |
| Interest Income | ₹15.28L | ₹0.00L | ₹0.67L | ₹0.16L | ₹2.10L |
| Interest Expense | ₹0.91L | ₹3.61L | ₹4.15L | ₹4.19L | ₹0.00L |
| Operating Income | ₹37.73L | ₹46.80L | ₹41.72L | ₹73.86L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹91.89L | ₹115.18L | ₹130.42L | ₹126.40L | ₹0.00L |
| Normalized Income | ₹51.51L | ₹55.77L | ₹70.92L | ₹56.04L | ₹0.00L |
| Operating Expense | ₹205.71L | ₹208.81L | ₹211.06L | ₹187.33L | ₹0.00L |
| Operating Revenue | ₹2,839.52L | ₹3,340.22L | ₹4,003.53L | ₹3,003.52L | ₹0.00L |
| Net Interest Income | ₹14.27L | ₹0.73L | -₹4.15L | -₹4.09L | ₹0.00L |
| Total Unusual Items | ₹281.18L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹162.74L | ₹162.74L | ₹162.74L | ₹162.74L | ₹0.00L |
| Diluted Average Shares | ₹162.74L | ₹162.74L | ₹162.74L | ₹162.74L | ₹0.00L |
| Total Other Finance Cost | ₹0.10L | ₹0.00L | ₹0.20L | ₹0.06L | ₹0.16L |
| Net Income Extraordinary | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Operating Expenses | ₹72.09L | ₹73.37L | ₹88.85L | ₹66.63L | ₹0.00L |
| Reconciled Depreciation | ₹27.20L | ₹37.96L | ₹39.94L | ₹42.91L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹2,596.08L | ₹3,084.61L | ₹3,750.75L | ₹2,742.33L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹54.09L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Income Non Operating | ₹15.28L | ₹0.00L | ₹0.67L | ₹0.16L | ₹2.10L |
| Selling And Marketing Expense | ₹1.07L | ₹1.17L | ₹1.16L | ₹1.62L | ₹0.00L |
| Interest Expense Non Operating | ₹0.91L | ₹3.61L | ₹3.95L | ₹4.19L | ₹0.00L |
| Net Income Common Stockholders | ₹278.60L | ₹55.77L | ₹70.92L | ₹56.04L | ₹0.00L |
| Net Income Continuous Operations | ₹278.60L | ₹55.78L | ₹70.92L | ₹56.04L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹278.60L | ₹55.77L | ₹70.92L | ₹56.04L | ₹0.00L |
| General And Administrative Expense | ₹25.37L | ₹17.81L | ₹14.01L | ₹13.63L | ₹0.00L |
| Selling General And Administration | ₹26.44L | ₹18.98L | ₹15.17L | ₹15.25L | ₹0.00L |
| Net Income Discontinuous Operations | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹281.18L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹14.27L | ₹0.73L | -₹4.15L | -₹4.09L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹278.60L | ₹55.78L | ₹70.92L | ₹56.04L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹278.60L | ₹55.77L | ₹70.92L | ₹56.04L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹278.60L | ₹55.77L | ₹70.92L | ₹56.04L | ₹0.00L |
Company Performance (FY23–FY26)
₹40.0 Cr₹30.0 Cr₹20.0 Cr₹10.0 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 25/08/2020 | Ketan Shah | 08818212 | Managing Director | View other directorships |
| 25/08/2020 | Ashok Kumar Ramawat | 08818263 | Director | View other directorships |
| 30/06/2021 | Satish Beohar | 09220291 | Director | View other directorships |
| 14/11/2022 | Pavan Singh Rajput | *****8147J | CFO | |
| 14/08/2023 | Gayatri Padiyar | 10260173 | Director | View other directorships |
| 30/12/2024 | Meet Shah | 06578351 | Director | View other directorships |
| 19/04/2025 | Apoorv Jain | *****4678A | Company Secretary | |
| 23/08/2025 | Smitesh Shah | 00326182 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 8
- Ketan ShahManaging Director
- Smitesh ShahDirector
- Meet ShahDirector
- Gayatri PadiyarDirector
- Satish BeoharDirector
- Ashok Kumar RamawatDirector
- Apoorv JainCompany Secretary
- Pavan Singh RajputCFO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 20/11/2024 | Form MGT-7-20112024_signed | - |
| 29/10/2024 | Form AOC-4(XBRL)-29102024_signed | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AB6724675 | 03/09/2025 | ₹2,85,00,000.00 | Idfc First Bank Limited |
| Y10305428 | 07/12/1998 | ₹4,00,00,000.00 | Industrial Development Bank Of India |
| A00985911 | 12/07/1996 | ₹0.00 | Canara Bank |
| Y10305013 | 12/09/1995 | ₹10,00,00,000.00 | Industrial Development Bank Of India |
| A00986059 | 13/03/1995 | ₹0.00 | Canara Bank |
| A00986000 | 13/03/1995 | ₹0.00 | Canara Bank |
| A00985838 | 12/01/1995 | ₹0.00 | Canara Bank |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
B/12-b, Industrial Estate, Pologround, Industrial Estate (indore), Indore, Indore, Madhya Pradesh, India, 452015
Frequently Asked Questions
What is the incorporation date of Biofil Chemicals And Pharmaceuticals Limited?
The incorporation date of Biofil Chemicals And Pharmaceuticals Limited is 03/01/1985.
What is the authorized share capital and paid-up capital of Biofil Chemicals And Pharmaceuticals Limited?
The authorized share capital of Biofil Chemicals And Pharmaceuticals Limited is ₹20,00,00,000.00. The paid-up capital is ₹16,27,38,000.00.
Who are the current board members & directors of Biofil Chemicals And Pharmaceuticals Limited?
The current board member of Biofil Chemicals And Pharmaceuticals Limited are:
- Ketan Shah
- Satish Beohar
- Ashok Kumar Ramawat
- Pavan Singh Rajput
- Smitesh Shah
- Apoorv Jain
- Meet Shah
- Gayatri Padiyar
What is the registered address of Biofil Chemicals And Pharmaceuticals Limited?
The registered address of Biofil Chemicals And Pharmaceuticals Limited is B/12-b, Industrial Estate, Pologround, Industrial Estate (indore), Indore, Indore, Madhya Pradesh, India, 452015.
What is the Corporate Identification Number of Biofil Chemicals And Pharmaceuticals Limited?
The Corporate Identification Number of Biofil Chemicals And Pharmaceuticals Limited is L24233MP1985PLC002709.